Open Access
CC BY-NC-ND 4.0 · Laryngorhinootologie 2018; 97(S 02): S131-S132
DOI: 10.1055/s-0038-1640165
Abstracts
Onkologie: Oncology

Expression of EpCAM and Sox2 as a Positive Prognosticator for Head and Neck Carcinoma Outcome

Authors

  • F Simon

    1   HNO LMU München, München

  • P Baumeister

    1   HNO LMU München, München

  • O Gires

    1   HNO LMU München, München
Further Information
Also available at
 

Locally advanced head and neck squamous cell carcinomas (HNSCC) have very limited prognosis due to frequent treatment failure and recurrence. Currently TNM-classification and human papillomavirus (HPV) infection are the sole clinical prognosticators of outcome. Tumor heterogeneity based on epithelial-mesenchymal-transition reportedly associates with therapy resistance of carcinomas. Therefore, expression of epithelial marker EpCAM (EpEX), reprogramming factor Sox2 and mesenchymal marker vimentin were assessed in a discovery cohort of HNSCC patients treated with surgery and adjuvant radio(chemo)therapy (n = 94). Expression of all three markers was heterogeneous in HNSCC. EpEX(high) and Sox2(high) predicted enhanced overall, disease-free and disease-specific survival in the entire cohort and, importantly, in the HPV-negative subgroup of the discovery cohort. Sox2(high) and EpEX(high) were confirmed as prognosticators in a validation cohort of HNSCC patients treated with definitive radio(chemo)therapy (n = 94). However, only EpEX(high) allowed identification of patients with improved survival endpoints within the HPV-negative subgroup of the validation cohort. Hence, Sox2(high) and particularly EpEX(high) have potential as tools for the prediction of clinical performance of HNSCC patients, foremost HPV-negative cases, in the frame of molecular-guided treatment decision-making.



Publication History

Publication Date:
18 April 2018 (online)

© 2018. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York